Town Hall – Biocompatibility and Toxicological Risk Assessment

The U.S. Food and Drug Administration (FDA) will host a town hall for industry stakeholders and other interested parties to discuss toxicological risk assessments used to address biocompatibility endpoints for medical devices. The session will focus on methods and considerations for conducting toxicological risk assessments in accordance with FDA-recognized standards, as well as examples of common deviations encountered during the evaluation process.

Visit the event page for more information.